Point of Care Diagnostics Market Report 2021-2031

ポイントオブケア(POC)診断の世界市場2021年-2031年

◆タイトル:Point of Care Diagnostics Market Report 2021-2031
◆商品コード:VGA21MA018
◆調査・発行会社:visiongain
◆発行日:2021年3月
◆ページ数:438
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle User(1名様閲覧用、1年間、印刷不可)USD5,199 ⇒換算¥597,885見積依頼/購入/質問フォーム
Global Site License(法人閲覧用、1年間、印刷可)USD9,099 ⇒換算¥1,046,385見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、世界のポイントオブケア(POC)診断の市場について調査・分析し、レポート概要、エグゼクティブサマリー、定性分析、製品別(血糖値監視、心臓代謝監視、感染症検査、凝固監視、妊娠・出産性検査)分析、方法別(処方箋ベース製品、店頭(OTC)製品)分析、エンドユーザー別(クリニック、病院、在宅医療、その他)分析、地域別分析、企業情報などの項目を掲載しています。
・レポート概要
・エグゼクティブサマリー
・定性分析
・世界のポイントオブケア(POC)診断市場規模:製品別(血糖値監視、心臓代謝監視、感染症検査、凝固監視、妊娠・出産性検査)
・世界のポイントオブケア(POC)診断市場規模:方法別(処方箋ベース製品、店頭(OTC)製品)
・世界のポイントオブケア(POC)診断市場規模:エンドユーザー別(クリニック、病院、在宅医療、その他)
・世界のポイントオブケア(POC)診断市場規模:地域別
・企業情報

Point-of-care diagnostics also known as near-patient testing is defined as an investigation taken at the time of the consultation with instant availability of results to make immediate and informed decisions about patient care. Point of care diagnostics market-our new study reveals current trends, technological advancements, and predicted revenues.

Where the Point of care diagnostics market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.

Owing to the COVID-19 pandemic, the supply chain and demand of point of care diagnostics has been affected in 2020. But it is not just COVID-19 that affects the future of point of care diagnostics. This unique senior report tells you what direction the market will take – and it tells you today.

Discover how to stay ahead

Our 430+ page report provides 600+ tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Point of care diagnostics Market. See how to exploit the opportunities.

UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

Forecasts to 2030 and other analyses reveal the commercial prospects

In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.
Which Factors are Fuelling Point of care diagnostics Industry Growth?
High prevalence of infectious diseases across the globe
Increasing Incidence of Target Conditions
Growing Government Support
Rising Number of CLIA Waived POC Tests
Which Factors are Restraining Growth?
Pricing Pressure owing to Reimbursement Cuts and Budget Constraints
Stringent and Time Consuming Regulatory Policies
How do prominent players strengthen their position throughout the world?

You must read this newly updated report if you are involved in this sector. The report from Visiongain gives you key potential revenues up to 2031, evaluates critical development information, trends, opportunities and business outlooks.

Forecasts to 2031 and other analyses reveal the commercial prospects
In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
You find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.
Report Scope

Global Point of Care Diagnostics Market 2021-2031 is segmented on the basis of Product, Mode, End User and Geography.
Revenue and growth forecasts from 2021 to 2031 for the Global Point of Care Diagnostics Market by Product:
Glucose Monitoring
Cardiometabolic Monitoring
Infectious Disease Testing
Coagulation Monitoring
Pregnancy & Fertility Testing
Cancer Marker Testing
Urinalysis Testing
Cholesterol Testing
Hematology Testing
Drugs-of-abuse Testing
Faecal Occult Testing
Other POC Products
Revenue and growth forecasts from 2021 to 2031 for the Global Point of Care Diagnostics Market by Mode:
Prescription-based
OTC
Revenue and growth forecasts from 2021 to 2031 for the Global Point of care diagnostics Market by End-User:
Clinics
Hospitals
Home Care Setting
Other End Users
Revenue and growth forecasts from 2021 to 2031 for the Global Point of care diagnostics Market by Region:
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of APAC
LAMEA
Brazil
Mexico
Rest of LAMEA

【レポートの目次】

1 Report Overview
1.1 Introduction to Global Point of Care Diagnostics Market
1.2 Global Point of Care Diagnostics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Qualitative Analysis of the Global Point of Care Diagnostic Market
3.1 SWOT Analysis
3.2 PEST Analysis
3.2.1 Political
3.2.2 Economic
3.2.3 Sociocultural
3.2.4 Technological
3.3 Drivers
3.3.1 High prevalence of infectious diseases across the globe
3.3.2 Increasing Incidence of Target Conditions
3.3.3 Growing Government Support
3.3.4 Rising Number of CLIA Waived POC Tests
3.4 Restraints
3.4.1 Pricing Pressure owing to Reimbursement Cuts and Budget Constraints
3.4.2 Stringent and Time Consuming Regulatory Policies
3.5 Opportunities
3.5.1 POC Tests with Multiplexing Capabilities
3.5.2 Healthcare Decentralization – Converting Lab Tests to POC Tests
3.6 Porter’s Five Forces Analysis
3.6.1 Moderate Bargaining Power of Supplier
3.6.2 High Bargaining Power of Buyer
3.6.3 Low Threat of New Entrants
3.6.4 High Threat of Substitutes
3.6.5 High Intensity of Competitive Rivalry
3.7 COVID-19 Impact Analysis
4 Global Point of Care Diagnostics Market, by Product, 2021-2031
4.1 Global Point of Care Diagnostics Market Forecast, 2021-2031
4.2 Glucose Monitoring
4.2.1 Global Point of Care Diagnostics Market for Glucose Monitoring by Region: Market Forecast, 2021-2031
4.2.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Glucose Monitoring: Recovery Scenarios (V, U, W, L)
4.3 Cardiometabolic Monitoring
4.3.1 Global Point of Care Diagnostics Market for Cardiometabolic Monitoring by Region: Market Forecast, 2021-2031
4.3.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Cardiometabolic Monitoring: Recovery Scenarios (V, U, W, L)
4.4 Infectious Disease Testing
4.4.1 Global Point of Care Diagnostics Market for Infectious Disease Testing by Region: Market Forecast, 2021-2031
4.4.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Infectious Disease Testing: Recovery Scenarios (V, U, W, L)
4.5 Coagulation Monitoring
4.5.1 Global Point of Care Diagnostics Market for Coagulation Monitoring by Region: Market Forecast, 2021-2031
4.5.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Coagulation Monitoring: Recovery Scenarios (V, U, W, L)
4.6 Pregnancy & Fertility Testing
4.6.1 Global Point of Care Diagnostics Market for Pregnancy & Fertility Testing by Region: Market Forecast, 2021-2031
4.6.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Pregnancy & Fertility Testing: Recovery Scenarios (V, U, W, L)
4.7 Tumour/Cancer Marker Testing
4.7.1 Global Point of Care Diagnostics Market for Tumour/Cancer Marker Testing by Region: Market Forecast, 2021-2031
4.7.1 COVID-19 Impact on Global Point of Care Diagnostics Market for Tumour/Cancer Marker Testing: Recovery Scenarios (V, U, W, L)
4.8 Urinalysis Testing
4.8.1 Global Point of Care Diagnostics Market for Urinalysis Testing by Region: Market Forecast, 2021-2031
4.8.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Urinalysis Testing: Recovery Scenarios (V, U, W, L)
4.9 Cholesterol Testing
4.9.1 Global Point of Care Diagnostics Market for Cholesterol Testing by Region: Market Forecast, 2021-2031
4.9.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Cholesterol Testing: Recovery Scenarios (V, U, W, L)
4.10 Hematology Testing
4.10.1 Global Point of Care Diagnostics Market for Hematology Testing by Region: Market Forecast, 2021-2031
4.10.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Hematology Testing: Recovery Scenarios (V, U, W, L)
4.11 Drugs-of-abuse Testing
4.11.1 Global Point of Care Diagnostics Market for Drugs-of-abuse Testing by Region: Market Forecast, 2021-2031
4.11.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Drugs-of-abuse Testing: Recovery Scenarios (V, U, W, L)
4.12 Faecal Occult Testing
4.12.1 Global Point of Care Diagnostics Market for Faecal Occult Testing by Region: Market Forecast, 2021-2031
4.12.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Faecal Occult Testing: Recovery Scenarios (V, U, W, L)
4.13 Other POC Products
4.13.1 Global Point of Care Diagnostics Market for Other POC Products by Region: Market Forecast, 2021-2031
4.13.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Other POC Products: Recovery Scenarios (V, U, W, L)
5 Global Point of Care Diagnostics Market, by Mode, 2021-2031
5.1 Prescription-based Products
5.1.1 Global Prescription-based Point of Care Diagnostics Market by Region: Market Forecast, 2021-2031
5.1.2 COVID-19 Impact on Global Prescription-based Point of Care Diagnostics Market, by Mode: Recovery Scenarios (V, U, W, L)
5.2 Over the Counter (OTC) Products
5.2.1 Global OTC Point of Care Diagnostics Market by Region: Market Forecast, 2021-2031
5.2.2 COVID-19 Impact on Global OTC Point of Care Diagnostics Market, by Mode: Recovery Scenarios (V, U, W, L)
6 Global Point of Care Diagnostics Market, by End User, 2021-2031
6.1 Clinics
6.1.1 Global Point of Care Diagnostics Market for Clinics by Region: Market Forecast, 2021-2031
6.1.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Clinics: Recovery Scenarios (V, U, W, L)
6.2 Hospitals
6.2.1 Point of Care Diagnostics Market Forecast for Hospitals by Region: Market Forecast, 2021-2031
6.2.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Hospitals: Recovery Scenarios (V, U, W, L)
6.3 Home Care Settings
6.3.1 Point of Care Diagnostics Market Forecast for Home Care Settings by Region: Market Forecast, 2021-2031
6.3.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Home Care Settings: Recovery Scenarios (V, U, W, L)
6.4 Other End-user
6.4.1 Point of Care Diagnostics Market Forecast for Other End Users by Region: Market Forecast, 2021-2031
6.4.2 COVID-19 Impact on Global Point of Care Diagnostics Market for Other End Users: Recovery Scenarios (V, U, W, L)
7 Global Point of Care Diagnostics Market Forecast, 2021-2031
8 North America Point of Care Diagnostics Market, 2021-2031
8.1.1 COVID-19 Impact on North America Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
8.2 North America Point of Care Diagnostics Market Forecast, by Product, 2021-2031
8.3 North America Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
8.4 North America Point of Care Diagnostics Market Forecast, by End User, 2021-2031
8.5 North America Point of Care Diagnostics Market Forecast, by Country, 2021-2031
8.6 U.S.
8.6.1 The U.S. accounted for the largest share of the North America point of care diagnostics market
8.6.2 U.S. Point of Care Diagnostics Market Forecast, 2021-2031
8.6.3 U.S. Point of Care Diagnostics Market Forecast, by Product, 2021-2031
8.6.4 U.S. Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
8.6.5 U.S. Point of Care Diagnostics Market Forecast, by End User, 2021-2031
8.6.6 COVID-19 Impact on U.S. Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
8.7 Canada
8.7.1 Government Support to Increase Adoption of POC Diagnostics Across Canadian Region
8.7.2 Canada Point of Care Diagnostics Market Forecast, 2021-2031
8.7.3 Canada Point of Care Diagnostics Market Forecast, by Product, 2021-2031
8.7.4 Canada Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
8.7.5 Canada Point of Care Diagnostics Market Forecast, by End User, 2021-2031
8.7.6 COVID-19 Impact on Canada Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
9 Europe Point of Care Diagnostics Market, 2021-2031
9.1.1 COVID-19 Impact on Europe Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.2 Europe Point of Care Diagnostics Market Forecast, by Product, 2021-2031
9.3 Europe Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
9.4 Europe Point of Care Diagnostics Market Forecast, by End User, 2021-2031
9.5 Europe Point of Care Diagnostics Market Forecast, by Country, 2021-2031
9.6 Germany
9.6.1 Increased focus to develop new POC testing devices
9.6.2 Germany Point of Care Diagnostics Market Forecast, 2021-2031
9.6.3 Germany Point of Care Diagnostics Market Forecast, by Product, 2021-2031
9.6.4 Germany Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
9.6.5 Germany Point of Care Diagnostics Market Forecast, by End User, 2021-2031
9.6.6 COVID-19 Impact on Germany Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.7 France
9.7.1 Availability of reimbursement for several POC products
9.7.2 France Point of Care Diagnostics Market Forecast, 2021-2031
9.7.3 France Point of Care Diagnostics Market Forecast, by Product, 2021-2031
9.7.4 France Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
9.7.5 France Point of Care Diagnostics Market Forecast, by End User, 2021-2031
9.7.6 COVID-19 Impact on France Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.8 UK
9.8.1 There is an increase in awareness regarding the benefits of using POC products
9.8.2 UK Point of Care Diagnostics Market Forecast, 2021-2031
9.8.3 UK Point of Care Diagnostics Market Forecast, by Product, 2021-2031
9.8.4 UK Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
9.8.5 UK Point of Care Diagnostics Market Forecast, by End User, 2021-2031
9.8.6 COVID-19 Impact on UK Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.9 Italy
9.9.1 Rise in prevalence of chronic disease is a major driving factor
9.9.2 Italy Point of Care Diagnostics Market Forecast, 2021-2031
9.9.3 Italy Point of Care Diagnostics Market Forecast, by Product, 2021-2031
9.9.4 Italy Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
9.9.5 Italy Point of Care Diagnostics Market Forecast, by End User, 2021-2031
9.9.6 COVID-19 Impact on Italy Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.10 Spain
9.10.1 Spain Point of Care Diagnostics Market Forecast, 2021-2031
9.10.2 Spain Point of Care Diagnostics Market Forecast, by Product, 2021-2031
9.10.3 Spain Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
9.10.4 Spain Point of Care Diagnostics Market Forecast, by End User, 2021-2031
9.10.5 COVID-19 Impact on Spain Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.11 Russia
9.11.1 Russia Point of Care Diagnostics Market Forecast, 2021-2031
9.11.2 Russia Point of Care Diagnostics Market Forecast, by Product, 2021-2031
9.11.3 Russia Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
9.11.4 Russia Point of Care Diagnostics Market Forecast, by End User, 2021-2031
9.11.5 COVID-19 Impact on Russia Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.12 Rest of Europe
9.12.1 Rest of Europe Point of Care Diagnostics Market Forecast, 2021-2031
9.12.2 Rest of Europe Point of Care Diagnostics Market Forecast, by Product, 2021-2031
9.12.3 Rest of Europe Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
9.12.4 Rest of Europe Point of Care Diagnostics Market Forecast, by End User, 2021-2031
9.12.5 COVID-19 Impact on Rest of Europe Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
10 Asia-Pacific Point of Care Diagnostics Market, 2021-2031
10.1 Asia-Pacific Point of Care Diagnostics Market Forecast, by Product, 2021-2031
10.2 Asia-Pacific Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
10.3 Asia-Pacific Point of Care Diagnostics Market Forecast, by End User, 2021-2031
10.4 Asia-Pacific Point of Care Diagnostics Market Forecast, by Country, 2021-2031
10.4.1 COVID-19 Impact on Asia-Pacific Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.5 Japan
10.5.1 Japan is the major contributor towards the growth of Asia-Pacific POC diagnostics
10.5.2 Japan Point of Care Diagnostics Market Forecast, 2021-2031
10.5.3 Japan Point of Care Diagnostics Market Forecast, by Product, 2021-2031
10.5.4 Japan Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
10.5.5 Japan Point of Care Diagnostics Market Forecast, by End User, 2021-2031
10.5.6 COVID-19 Impact on Japan Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.6 China
10.6.1 Increasing focus of market players will contribute towards the high growth of the China market
10.6.2 China Point of Care Diagnostics Market Forecast, 2021-2031
10.6.3 China Point of Care Diagnostics Market Forecast, by Product, 2021-2031
10.6.4 China Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
10.6.5 China Point of Care Diagnostics Market Forecast, by End User, 2021-2031
10.6.6 COVID-19 Impact on China Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.7 India
10.7.1 Rise in prevalence of chronic diseases will support the market growth
10.7.2 India Point of Care Diagnostics Market Forecast, 2021-2031
10.7.3 India Point of Care Diagnostics Market Forecast, by Product, 2021-2031
10.7.4 India Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
10.7.5 India Point of Care Diagnostics Market Forecast, by End User, 2021-2031
10.7.6 COVID-19 Impact on India Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.8 Australia
10.8.1 Increased incidence of chronic diseases such as diabetes and cancer
10.8.2 Australia Point of Care Diagnostics Market Forecast, 2021-2031
10.8.3 Australia Point of Care Diagnostics Market Forecast, by Product, 2021-2031
10.8.4 Australia Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
10.8.5 Australia Point of Care Diagnostics Market Forecast, by End User, 2021-2031
10.8.6 COVID-19 Impact on Australia Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.9 South Korea
10.9.1 Rise in funding for product innovation
10.9.2 South Korea Point of Care Diagnostics Market Forecast, 2021-2031
10.9.3 South Korea Point of Care Diagnostics Market Forecast, by Product, 2021-2031
10.9.4 South Korea Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
10.9.5 South Korea Point of Care Diagnostics Market Forecast, by End User, 2021-2031
10.9.6 COVID-19 Impact on South Korea Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.10 Rest of Asia-Pacific
10.10.1 Rest of Asia-Pacific Point of Care Diagnostics Market Forecast, 2021-2031
10.10.2 Rest of Asia-Pacific Point of Care Diagnostics Market Forecast, by Product, 2021-2031
10.10.3 Rest of Asia-Pacific Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
10.10.4 Rest of Asia-Pacific Point of Care Diagnostics Market Forecast, by End User, 2021-2031
10.10.5 COVID-19 Impact on Rest of Asia-Pacific Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
11 Latin America Middle East and Africa (LAMEA) Point of Care Diagnostics Market, 2021-2031
11.1 LAMEA Point of Care Diagnostics Market Forecast, by Product, 2021-2031
11.2 LAMEA Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
11.3 LAMEA Point of Care Diagnostics Market Forecast, by End User, 2021-2031
11.4 LAMEA Point of Care Diagnostics Market Forecast, by Country, 2021-2031
11.4.1 COVID-19 Impact on LAMEA Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
11.5 Brazil
11.5.1 Brazil is the dominant country in the LAMEA POC Diagnostics Market
11.5.2 Brazil Point of Care Diagnostics Market Forecast, 2021-2031
11.5.3 Brazil Point of Care Diagnostics Market Forecast, by Product, 2021-2031
11.5.4 Brazil Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
11.5.5 Brazil Point of Care Diagnostics Market Forecast, by End User, 2021-2031
11.5.6 COVID-19 Impact on Brazil Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
11.6 Mexico
11.6.1 Increase in healthcare budget among patient population
11.6.2 Mexico Point of Care Diagnostics Market Forecast, 2021-2031
11.6.3 Mexico Point of Care Diagnostics Market Forecast, by Product, 2021-2031
11.6.4 Mexico Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
11.6.5 Mexico Point of Care Diagnostics Market Forecast, by End User, 2021-2031
11.6.6 COVID-19 Impact on Mexico Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
11.7 Rest of LAMEA
11.7.1 Rest of LAMEA Point of Care Diagnostics Market Forecast, 2021-2031
11.7.2 Rest of LAMEA Point of Care Diagnostics Market Forecast, by Product, 2021-2031
11.7.3 Rest of LAMEA Point of Care Diagnostics Market Forecast, by Mode, 2021-2031
11.7.4 Rest of LAMEA Point of Care Diagnostics Market Forecast, by End User, 2021-2031
11.7.5 COVID-19 Impact on Rest of LAMEA Point of Care Diagnostics Market: Recovery Scenarios (V, U, W, L)
12 Company Profile
12.1 Market Share Analysis
12.1.1 Point of Care Diagnostic Market: Market Share Analysis
12.2 Abbott Laboratories
12.2.1 Company Overview
12.2.2 Company Snapshot
12.2.3 Product Portfolio
12.2.4 Financial Analysis
12.2.4.1 Net Revenue, 2015-2019
12.2.4.2 Segmental Revenue Shares, 2019
12.2.4.3 Regional Revenue Shares, 2019
12.2.5 Recent Developments 2019
12.3 Roche
12.3.1 Company Overview
12.3.2 Company Snapshot
12.3.3 Product Portfolio
12.3.4 Financial Analysis
12.3.4.1 Net Revenue, 2015-2019
12.3.4.2 Segmental Revenue Shares, 2019
12.3.4.3 Regional Revenue Shares, 2019
12.3.5 Recent Developments, 2019
12.4 Quidel
12.4.1 Company Overview
12.4.2 Company Snapshot
12.4.3 Product Portfolio
12.4.4 Financial Analysis
12.4.4.1 Net Revenue, 2015-2019
12.4.4.2 Segmental Revenue Shares, 2019
12.4.4.3 Regional Revenue Shares, 2019
12.5 AccuBiotech
12.5.1 Company Overview
12.5.2 Company Snapshot
12.5.3 Product Portfolio
12.6 Johnson & Johnson
12.6.1 Company Overview
12.6.2 Company Snapshot
12.6.3 Product Portfolio
12.6.4 Financial Analysis
12.6.4.1 Net Revenue, 2015-2019
12.6.4.2 Segmental Revenue Shares, 2019
12.6.4.3 Regional Revenue Shares, 2019
12.6.5 Recent Developments, 2018
12.7 Becton, Dickinson, and Company
12.7.1 Company Overview
12.7.2 Company Snapshot
12.7.3 Product Portfolio
12.7.4 Financial Analysis
12.7.4.1 Net Revenue, 2016-2020
12.7.4.2 Segmental Revenue Shares, 2019
12.7.4.3 Regional Revenue Shares, 2019
12.7.5 Recent Developments, 2020
12.8 Danaher Corporation
12.8.1 Company Overview
12.8.2 Company Snapshot
12.8.3 Product Portfolio
12.8.4 Financial Analysis
12.8.4.1 Net Revenue, 2015-2019
12.8.4.2 Segmental Revenue Shares, 2019
12.8.4.3 Regional Revenue Shares, 2019
12.8.5 Recent Developments 2020
12.9 PTS Diagnostics
12.9.1 Company Overview
12.9.2 Company Snapshot
12.9.3 Product Portfolio
12.9.4 Recent Developments, 2018-2020
12.10 Trinity Biotech
12.10.1 Company Overview
12.10.2 Company Snapshot
12.10.3 Product Portfolio
12.10.4 Financial Analysis
12.10.4.1 Net Revenue, 2017-2020
12.10.4.2 Segmental Revenue Shares, 2020
12.10.4.3 Regional Revenue Shares, 2020
12.10.5 Recent Developments, 2018-2021
12.11 Siemens Healthineers Group
12.11.1 Company Overview
12.11.2 Company Snapshot
12.11.3 Product Portfolio
12.11.4 Financial Analysis
12.11.4.1 Net Revenue, 2017-2020
12.11.4.2 Segmental Revenue Shares, 2020
12.11.4.3 Regional Revenue Shares, 2020
12.11.5 Recent Developments, 2018-2020
12.12 Sekisui Diagnostics Group
12.12.1 Company Overview
12.12.2 Company Snapshot
12.12.3 Product Portfolio
12.12.4 Recent Developments, 2017-2020
12.13 Fluxergy
12.13.1 Company Overview
12.13.2 Company Snapshot
12.13.3 Product Portfolio
12.13.4 Recent Developments 2020
12.14 Chembio Diagnostics
12.14.1 Company Overview
12.14.2 Company Snapshot
12.14.3 Product Portfolio
12.14.4 Financial Analysis
12.14.4.1 Net Revenue, 2015-2019
12.14.4.2 Segmental Revenue Shares, 2019
12.14.4.3 Regional Revenue Shares, 2019
12.14.5 Recent Developments, 2017-2020
12.15 Instrumentation Laboratory (A Werfen Company)
12.15.1 Company Overview
12.15.2 Company Snapshot
12.15.3 Product Portfolio
12.15.4 Recent Developments, 2017-2020
12.16 Nova Biomedical
12.16.1 Company Overview
12.16.2 Company Snapshot
12.16.3 Product Portfolio
12.16.4 Recent Developments, 2017-2020
13 Conclusion and Recommendations
13.1 Conclusion
13.2 Recommendations



★調査レポート[ポイントオブケア(POC)診断の世界市場2021年-2031年] ( Point of Care Diagnostics Market Report 2021-2031 / VGA21MA018) 販売に関する免責事項
[ポイントオブケア(POC)診断の世界市場2021年-2031年] ( Point of Care Diagnostics Market Report 2021-2031 / VGA21MA018) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆